Location History:
- Basel, CH (2015)
- San Francisco, CA (US) (2017 - 2023)
Company Filing History:
Years Active: 2015-2025
Title: Janos Redei: Innovator in Alzheimer's Disease and Therapeutic Interventions
Introduction
Janos Redei is a prominent inventor based in San Francisco, CA, known for his significant contributions to the fields of personalized medicine and therapeutic interventions. With a total of 9 patents to his name, Redei has focused on developing innovative solutions for complex health issues, particularly Alzheimer's disease.
Latest Patents
One of Redei's latest patents addresses personalized medicine for Alzheimer's disease. This method involves detecting single nucleotide polymorphisms (SNPs) in human subjects by obtaining a nucleic acid sample and genotyping it for specific Alzheimer's disease-associated genes. The process includes detecting the presence of certain alleles, which can provide valuable insights into the genetic predisposition to the disease.
Another notable patent focuses on non-invasive and non-contact measurement techniques for assessing a subject's tremor. This system utilizes sensors to measure the position or motion of an extremity, allowing for remote analysis of tremor severity. Such innovations are crucial for early therapeutic interventions and improving patient care.
Career Highlights
Throughout his career, Redei has worked with various companies, including I2dx, Inc. His work has consistently aimed at bridging the gap between technology and healthcare, making significant strides in how diseases are diagnosed and treated.
Collaborations
Redei has collaborated with notable individuals in his field, including Matthew J Johnson and Ethan C Green. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Janos Redei's innovative work in personalized medicine and therapeutic interventions showcases his commitment to improving healthcare outcomes. His patents reflect a deep understanding of the complexities of diseases like Alzheimer's and the importance of early intervention strategies.